MedPath

CANCIDAS

These highlights do not include all the information needed to use CANCIDAS safely and effectively. See full prescribing information for CANCIDAS. CANCIDAS® (caspofungin acetate) for injection, for intravenous useInitial U.S. Approval: 2001

Approved
Approval ID

3bad23a6-09a6-4194-9182-093ed61bc71c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 20, 2023

Manufacturers
FDA

Merck Sharp & Dohme LLC

DUNS: 118446553

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CASPOFUNGIN ACETATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0006-3822
Application NumberNDA021227
Product Classification
M
Marketing Category
C73594
G
Generic Name
CASPOFUNGIN ACETATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 11, 2022
FDA Product Classification

INGREDIENTS (5)

CASPOFUNGIN ACETATEActive
Quantity: 5 mg in 1 mL
Code: VUW370O5QE
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
MANNITOLInactive
Quantity: 2.4 mg in 1 mL
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SUCROSEInactive
Quantity: 3.6 mg in 1 mL
Code: C151H8M554
Classification: IACT

CASPOFUNGIN ACETATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0006-3823
Application NumberNDA021227
Product Classification
M
Marketing Category
C73594
G
Generic Name
CASPOFUNGIN ACETATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 11, 2022
FDA Product Classification

INGREDIENTS (5)

CASPOFUNGIN ACETATEActive
Quantity: 7 mg in 1 mL
Code: VUW370O5QE
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
MANNITOLInactive
Quantity: 3.3 mg in 1 mL
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SUCROSEInactive
Quantity: 5.0 mg in 1 mL
Code: C151H8M554
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CANCIDAS - FDA Drug Approval Details